News

Current Issue

Oncology

Overall Survival Improves With Adjuvant Pembrolizumab in RCC

A third prespecified interim analysis of the KEYNOTE-564 trial has determined that adjuvant pembrolizumab after surgery was associated with a significant and clinically meaningful improvement in overall survival, as compared with placebo, among participants with clear-cell renal-cell carcinoma at increased risk for recurrence after surgery.

Editor-In-Chief, Chester “Trip” Buckenmaier III, MD, COL (ret.), MC, USA

Change Takes Courage

I am tapping out this editorial on my 60th birthday in May. I prefer the annual and unavoidable nonevent—which is the date of my birth—to go by quietly and without too much hoopla. Family and friends have been asking if I feel any different at 60. I have responded that it seems no different from how I felt yesterday at 59. That is not to suggest I have not noticed the changes to my appearance associated with aging as I gaze in the mirror. I have no idea where all the gray hair is coming from (damned barber) or why less of it seems to be growing on my head but has sprouted with renewed aggressive vigor from my nose and ear canals (God does have a sense of humor).

read more

Reducing the Number of PPI Prescriptions: Benefits and Potential Pitfalls

One of the most commonly prescribed classes of drugs, proton pump inhibitors (PPIs), reduces the risk of gastrointestinal bleeding in certain patients at increased risk. Most PPI prescriptions are written for other reasons, however. In fact, an estimated 25-70% of PPI users might not have an appropriate indication.

Legislators Told AI Both Promising, Scary for Improving VA Healthcare

The speed at which artificial intelligence (AI) is being embraced at the VA has legislators both hopeful and concerned, optimistic that it can improve veterans’ health but worried about data privacy and the possibility of software superseding human decision-making in clinical settings.

Change Takes Courage

I am tapping out this editorial on my 60th birthday in May. I prefer the annual and unavoidable nonevent—which is the date of my birth—to go by quietly and without too much hoopla. Family and friends have been asking if I feel any different at 60. I have responded that it seems no different from how I felt yesterday at 59. That is not to suggest I have not noticed the changes to my appearance associated with aging as I gaze in the mirror. I have no idea where all the gray hair is coming from (damned barber) or why less of it seems to be growing on my head but has sprouted with renewed aggressive vigor from my nose and ear canals (God does have a sense of humor).

read more